<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><link rel="stylesheet" type="text/css" href="style.css"/><link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css" integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm" crossorigin="anonymous" /><title></title></head><body><div class="container"><h1>CFM23068:</h1><h2>FRS 102: Impairment: Accounting Treatment</h2><hr /><div contenteditable="true" class="container" style="width: 50%; height: 50%; float:left;"><h3>Old version</h3><hr /><p></p><h3>Treatment of impairment losses</h3><p>FRS 102 requires that where there is objective evidence of impairment, the entity recognises the impairment loss in the profit or loss immediately. </p><h3>Measurement of impairment loss</h3><p>FRS 102 states that an impairment loss shall be measured:</p><li><lilabel>1</lilabel><p>For an instrument measured at amortised cost, the impairment loss is the difference between the assets carrying value and the present value of the estimated future cash flows discounted at the assets original effective interest rate (where interest is variable the current effective interest rate is used).</p></li><li><lilabel>2</lilabel><p>For an instrument carried at cost less impairment, the impairment loss is measured as the difference between the assets carrying value and the best estimate of the amount which would be received if the asset was sold at the reporting date</p></li><p></p><li><lilabel></lilabel><p><remotelink dpsi="0Y02" refpt="0Y02_CFM23065:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Previous page </remotelink></p></li><li><lilabel></lilabel><p><remotelink dpsi="0Y02" refpt="0Y02_CFM23070:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Next page </remotelink></p></li></div><div contenteditable="true" class="container" style="width: 50%; height: 50%; float:right;"><h3>New version</h3><hr /><p></p><h3>Treatment of impairment losses</h3><p>FRS 102 requires that where there is objective evidence of impairment, the entity recognises the impairment loss in the profit or loss immediately.</p><h3>Measurement of impairment loss</h3><p>FRS 102 states that an impairment loss shall be measured:</p><li><lilabel>1</lilabel><p>For an instrument measured at amortised cost, the impairment loss is the difference between the assets carrying value and the present value of the estimated future cash flows discounted at the assets original effective interest rate (where interest is variable the current effective interest rate is used).</p></li><li><lilabel>2</lilabel><p>For an instrument carried at cost less impairment, the impairment loss is measured as the difference between the assets carrying value and the best estimate of the amount which would be received if the asset was sold at the reporting date</p></li><p></p><li><lilabel></lilabel><p><remotelink dpsi="0Y04" refpt="0Y04_CFM23065:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Previous page </remotelink></p></li><li><lilabel></lilabel><p><remotelink dpsi="0Y04" refpt="0Y04_CFM23070:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Next page </remotelink></p></li></div></div></body></html>